Profile
International Journal of Clinical Nutrition & Dietetics Volume 4 (2018), Article ID 4:IJCND-134, 8 pages
https://doi.org/10.15344/2456-8171/2018/134
Research Article
Special Issue: Functional Foods and Nutraceuticals: Their Role in Disease Prevention
Oral Administration of S-acetyl-glutathione: Impact on the Levels of Glutathione in Plasma and in Erythrocytes of Healthy Volunteers

Sergio Fanelli1, Antonio Francioso1, Rosaria A. Cavallaro*2, Maria d'Erme1, Pietro Putignano3, Niccolò Miraglia4 and Luciana Mosca1*

1Department of Biochemical Sciences A. Rossi Fanelli, Sapienza University of Rome, Italy
2Department of Surgery P. Valdoni, Sapienza University of Roma, Italy
3Diabetic Outpatient Clinic, ASST Monza, Italy
4Clinical & Pre-clinical Development, Gnosis SpA, Milan, Italy
Dr. Rosaria A. Cavallaro, Department of Surgery, P. Valdoni Sapienza University, Via Scarpa, 1400161 Roma, Italy, Tel: +39- 0649916604; E-mail: rosaria.cavallaro@uniroma1.it
Dr. Luciana Mosca, Department of Biochemical Sciences, Sapienza University, p.le Aldo Moro, 500185 Roma, Italy, Tel: +390649910987; E-mail: luciana.mosca@uniroma1.it
12 April 2018; 04 July 2018; 06 July 2018
Fanelli S, Francioso A, Cavallaro RA, d'Erme M, Mosca L, et al. (2018) Oral Administration of S-acetyl-glutathione: Impact on the Levels of Glutathione in Plasma and in Erythrocytes of Healthy Volunteers. Int J Clin Nutr Diet 4: 134. doi: https://doi.org/10.15344/2456-8171/2018/134

References

  1. Exner R, Wessner B, Manhart N, Roth E (2000) Therapeutic potential of glutathione. Wien Klin Wochenschr 112: 610-616 [Google Scholar] [PubMed]
  2. Liu Y, Hyde AS, Simpson MA, Barycki JJ (2014) Emerging regulatory paradigms in glutathione metabolism. Adv Cancer Res 122: 69-101 [CrossRef] [Google Scholar] [PubMed]
  3. Pham-Huy LA, He H, Pham-Huy C (2008) Free Radicals, Antioxidants in Disease and Health. Int J Biomed Sci 4: 89-96 [Google Scholar] [PubMed]
  4. Witschi A, Reddy S, Stofer B, Lauterburg BH (1992) The systemic availability of oral glutathione. Eur J Clin Pharmacol 43: 667-669 [CrossRef] [Google Scholar] [PubMed]
  5. Hunjan MK, Evered DF (1985) Absorption of glutathione from the gastrointestinal tract. Biochim Biophys Acta 815: 184-188 [CrossRef] [Google Scholar] [PubMed]
  6. Cascinu S, Cordella L, Del Ferro E, Fronzoni M, Catalano G, et al. (1995) Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial. J Clin Oncol. 13: 26-32 [CrossRef] [Google Scholar] [PubMed]
  7. Fraternale A, Paoletti MF, Casabianca A, Orlandi C, Schiavano GF, et al. (2008) Inhibition of murine AIDS by pro-glutathione (GSH) molecules. Antiviral Res 77: 120-127 [CrossRef] [Google Scholar] [PubMed]
  8. Cacciatore I, Cornacchia C, Pinnen F, Mollica A, Di Stefano A, et al. (2010) Prodrug approach for increasing cellular glutathione levels. Molecules 15: 1242-1264 [CrossRef] [Google Scholar] [PubMed]
  9. Vogel JU, Cinatl J, Dauletbaev N, Buxbaum S, Treusch G, et al. (2005) Effects of S-acetylglutathione in cell and animal model of herpes simplex virus type 1 infection. Med Microbiol Immunol 194: 55-59 [CrossRef] [Google Scholar] [PubMed]
  10. Schmitt B, Vicenzi M, Garrel C, Denis FM (2015) Effects of N-acetylcysteine, oral glutathione (GSH) and a novel sublingual form of GSH on oxidative stress markers: A comparative crossover study. Redox Biol 6: 198-205 [CrossRef] [Google Scholar] [PubMed]
  11. Levy EJ, Anderson ME, Meister A (1994) Preparation and properties of glutathione ester and related derivatives. Methods Enzymol. 234: 499-505 [CrossRef] [Google Scholar] [PubMed]
  12. Okun JG, Sauer S, Bähr S, Lenhartz H, Mayatepek E, et al. (2004) S-Acetylglutathione normalizes intracellular glutathione content in cultured fibroblasts from patients with glutathione synthetase deficiency. J Inherit Metab Dis. 27: 783-786 [CrossRef] [Google Scholar] [PubMed]
  13. Locigno R, Pincemail J, Henno A, Treusch G, Castronovo V, et al. ( 2002) S-acetyl-glutathione selectively induces apoptosis in human lymphoma cells through a GSH-independent mechanism. Int J Oncol 20: 69-75 [Google Scholar] [PubMed]
  14. Guidance on the investigation of bioequivalence. CPMP/EWP/ QWP/1401/98 Rev. 1/Corr ** [View]
  15. Wang W, Ballatori N (1998) Endogenous glutathione conjugates: occurrence and biological functions. Pharmacol Rev 50: 335-356 [Google Scholar] [PubMed]
  16. Hagen TM, Wierzbicka GT, Sillau AH, Bowman BB, Jones DP, et al. (1990) Bioavailability of dietary glutathione: effect on plasma concentration. Am J Physiol 259: G524-G529 [CrossRef] [Google Scholar] [PubMed]
  17. Aw TY, Wierzbicka G, Jones DP (1991) Oral glutathione increases tissue glutathione in vivo. Chem Biol Interact 80: 89-97 [CrossRef] [Google Scholar] [PubMed]
  18. Trickler D, Shklar G, Schwartz J (1993) Inhibition of oral carcinogenesis by glutathione. Nutr Cancer 20: 139-144 [CrossRef] [Google Scholar] [PubMed]
  19. Cai J, Chen Y, Seth S, Furukawa S, Compans RW, et al. (2003) Inhibition of influenza infection by glutathione. Free Radic Biol Med 34: 928-936 [CrossRef] [Google Scholar] [PubMed]
  20. Richie JP Jr, Nichenametla S, Neidig W, Calcagnotto A, Haley JS, et al. (2015) Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr. 54: 251-263 [CrossRef] [Google Scholar] [PubMed]
  21. Allen J, Bradley RD (2011) Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. J Altern Complement Med 17: 827-833 [CrossRef] [Google Scholar] [PubMed]
  22. Smyth JF, Bowman A, Perren T, Wilkinson P, Prescott RJ, et al. (1997) Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a doubleblind, randomised trial. Ann Oncol 8: 569-573 [CrossRef] [Google Scholar] [PubMed]
  23. Milla P, Airoldi M, Weber G, Drescher A, Jaehde U, et al. (2009) Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity. Anticancer Drugs 20: 396-402 [CrossRef] [Google Scholar] [PubMed]
  24. Anderson ME, Levey EJ, Meister A (1994) Preparation and use of glutathione monoesters. Methods Enzymol. 234: 492-499 [CrossRef] [Google Scholar]
  25. Anderson ME, Nilsson M, Sims NR. (2004) Glutathione monoethyl ester prevent mitochondrial glutathione depletion during focal cerebral ischemia. Neurochem Int 44: 153-159 [CrossRef] [Google Scholar] [PubMed]
  26. Galzigna L, Rizzoli V, Schiapelli P, Moretto C, Bernareggi A, et al. (1995) S-Acetyl and S-phenylacetyl-glutathione as glutathione precursors in rat plasma and tissue preparations. Enzyme Protein 48: 98-104 [Google Scholar] [PubMed]
  27. Rizzoli V, Schiappelli P, Moretto C, Galzigna L (1995) S-acetyl and S-phenylacethyl-glutathione in rat brain tissue. Eur J Lab Med 3: 11-13
  28. Fraternale A, Paoletti MF, Casabianca A, Nencioni L, Garaci E, et al. (2009) GSH and analogs in antiviral therapy. Mol Aspects Med 30: 99-110 [CrossRef] [Google Scholar] [PubMed]
  29. Park EY, Shimura N, Konishi T, Sauchi Y, Wada S, et al. (2014) Increase in the protein-bound form of glutathione in human blood after the oral administration of glutathione. J Agric Food Chem 62: 6183-6189 [CrossRef] [Google Scholar] [PubMed]
  30. Kleinman WA, Richie JP Jr (2000) Status of glutathione and other thiols and disulfides in human plasma. Biochem Pharmacol 60: 19-29 [CrossRef] [Google Scholar] [PubMed]
  31. Pastore A, Massoud R, Motti C, Lo Russo A, Fucci G, et al. (1998) Fully automated assay for total homocysteine, cysteine, cysteinylglycine, glutathione, cysteamine and 2-mercaptopropionylglycine in plasma and urine. Clin Chem 44: 825-832 [Google Scholar] [PubMed]
  32. Hong SY, Gil HW, Yang JO, Lee EY, Kim HK, et al. (2005) Pharmacokinetics of glutathione and its metabolites in normal subjects. J Korean Med Sci 20: 721-726 [CrossRef] [Google Scholar] [PubMed]